These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7515633)

  • 21. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
    Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
    J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mercury chloride modulation of the GABAA receptor-channel complex in rat dorsal root ganglion neurons.
    Huang CS; Narahashi T
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):508-20. PubMed ID: 8887468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relating ligand binding to activation gating in CNGA2 channels.
    Biskup C; Kusch J; Schulz E; Nache V; Schwede F; Lehmann F; Hagen V; Benndorf K
    Nature; 2007 Mar; 446(7134):440-3. PubMed ID: 17322905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Channel inhibition by alkanols occurs at a binding site on the nicotinic acetylcholine receptor.
    Wood SC; Tonner PH; de Armendi AJ; Bugge B; Miller KW
    Mol Pharmacol; 1995 Jan; 47(1):121-30. PubMed ID: 7530805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereoselective blockade of amphibian epithelial sodium channels by amiloride analogs.
    Li JH; Shaw A; Kau ST
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1081-4. PubMed ID: 8263768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The structure and function of glutamate receptor ion channels.
    Madden DR
    Nat Rev Neurosci; 2002 Feb; 3(2):91-101. PubMed ID: 11836517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cooperative interactions between general anesthetics and QX-222 within the pore of the acetylcholine receptor ion channel.
    Dilger JP; Vidal AM
    Mol Pharmacol; 1994 Jul; 46(1):169-75. PubMed ID: 7520126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacology of mechanogated membrane ion channels.
    Hamill OP; McBride DW
    Pharmacol Rev; 1996 Jun; 48(2):231-52. PubMed ID: 8804105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Progress and outlook in the development of pharmacology].
    Kharkevich DA
    Farmakol Toksikol; 1989; 52(6):106-20. PubMed ID: 2483140
    [No Abstract]   [Full Text] [Related]  

  • 30. Channel-linked receptors--from subunits to novel drug targets.
    Ahtee L; Tuominen RK
    Trends Pharmacol Sci; 1999 Oct; 20(10):391-3. PubMed ID: 10577250
    [No Abstract]   [Full Text] [Related]  

  • 31. 1994 Receptor and Ion Channel Nomenclature.
    Trends Pharmacol Sci; 1994; Suppl():1-51. PubMed ID: 7514318
    [No Abstract]   [Full Text] [Related]  

  • 32. 'Inhibitory' receptors and ion channel effectors.
    García-Sáinz JA
    Trends Pharmacol Sci; 1988 Aug; 9(8):271-2. PubMed ID: 2471339
    [No Abstract]   [Full Text] [Related]  

  • 33. Review of the basic principles of drug action.
    Hester RK; Tenner TE
    Semin Nephrol; 1986 Sep; 6(3):189-99. PubMed ID: 2440087
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug receptor interactions. Basis for the action of foreign substances. I].
    Kurz H
    Med Monatsschr Pharm; 1987 May; 10(5):132-8. PubMed ID: 3600489
    [No Abstract]   [Full Text] [Related]  

  • 35. Promiscuity in pharmacology.
    Ariëns EJ
    Trends Pharmacol Sci; 1988 Jul; 9(7):235. PubMed ID: 3247676
    [No Abstract]   [Full Text] [Related]  

  • 36. The stereoselectivity of drug action.
    Smith DF
    Pharmacol Toxicol; 1989 Nov; 65(5):321-31. PubMed ID: 2695914
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug chirality and its clinical significance.
    Hutt AJ; Tan SC
    Drugs; 1996; 52 Suppl 5():1-12. PubMed ID: 8922553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the other hand: the stereoselectivity of drug action at ion channels.
    Triggle DJ
    Chirality; 1994; 6(2):58-62. PubMed ID: 7515633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chiral aspects of drug action at ion channels: a commentary on the stereoselectivity of drug actions at voltage-gated ion channels with particular reference to verapamil actions at the Ca2+ channel.
    Kwon YW; Triggle DJ
    Chirality; 1991; 3(5):393-404. PubMed ID: 1721828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.
    Huber I; Wappl E; Herzog A; Mitterdorfer J; Glossmann H; Langer T; Striessnig J
    Biochem J; 2000 May; 347 Pt 3(Pt 3):829-36. PubMed ID: 10769189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.